financial_disclosure

SHERIDAN, WYOMING -- August 27, 2026 -- Luxshare Precision Industry Co., Ltd. (SZSE: 002475; HKEX: 02475) reported revenue of RMB 174.50 billion for the six months ended June 30, 2026, up 40.2% year over year. The Dongguan, China-based manufacturer posted net profit attributable to shareholders of RMB 7.84 billion, a rise of 18.0%. Gross margin expanded 17 basis points to 11.78%, driven by faster growth in higher-margin communications, data center and automotive electronics segments. The company disclosed the unaudited results on Aug. 28, 2026.

SHERIDAN, WYOMING -- August 27, 2026 -- AusperBio Therapeutics closed a $120 million Series C financing round on Aug. 27, 2026, bringing its total capital raised since 2024 to $360 million. The San Francisco-based biopharmaceutical company will direct proceeds toward Phase 3 registrational work and commercialization readiness for AHB-137, its lead antisense oligonucleotide therapy for chronic hepatitis B. RA Capital Management, L.P. joined the round as a new investor alongside an unnamed lead strategic investor.

Existing backers HanKang Capital, Sherpa Capital, InnoPinnacle Fund, Qiming Venture Partners, YuanBio Venture Capital and CDH Investments also participated. AusperBio described the round as reflecting sustained investor confidence in its oligonucleotide platforms.